Biofourmis enters the Unicorn Club


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Boston-based healthtech startup Biofourmis enters the Unicorn Club ($1 billion in valuation). The startup raised $300 million in its Series D funding round led by General Atlantic.

Boston-based health tech startup Biofourmis enters the Unicorn Club ($1 billion in valuation). The startup raised $300 million in its Series D funding round led by General Atlantic. Their current value has reached $1.3 billion. Other participants in the round were CVS Health and existing investors. 

Founded by Kuldeep Singh Rajput and co-founded by Mark Niu and Maulik Majumdar, the startup provides personalised and predictive care for patients. The startup has FDA approved hardware and software solutions to detect and predict diseases in patients. The startup believes that personalised patient care makes a great impact on the health and wellbeing of the patient.  

This round brings the startup’s total fund raised to around $445 million. They had raised $35 million in their Series B round and $100 million in their Series C round. Its investors include MassMutual Ventures, Sequoia Capital, SoftBank Vision Fund, Aviva Ventures, Openspace, Eden Strategy Insititute, SpesNet Pte. Ltd., EDBI and many more. 

CDC estimates that 6 in 10 American adults have 1 chronic disease whereas 4 in 10 suffer from 2 or more chronic diseases. The venture has 2 subsets - Biofourmis Therapeutics and Biofourmis Health. The startup's two acquisitions include a wearable biosensor named Biovotion and Takeda Pharmaceutical’s oncology-focused digital therapeutics company Gaido Health. 

Tags : #Biofourmis #KuldeepSinghRajput #MarkNiu #MaulikMajumdar #GeneralAtlantic #UnicornClub #MassMutualVentures #SequoiaCapital #SoftBankVisionFund #funding #fundingalert #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026